UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 89

Sortiert nach

AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms

Gut microbes, 2022-12, Vol.14 (1), p.2022997-2022997

2022

Link zum Volltext

Verfügbarkeit prüfen

Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders

Scandinavian journal of gastroenterology, 2014-12, Vol.49 (12), p.1419-1424

2014

Link zum Volltext

Verfügbarkeit prüfen

Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids

Gut microbes, 2019-01, Vol.10 (1), p.59-76

2019

Link zum Volltext

Verfügbarkeit prüfen

Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome

Gut microbes, 2022-12, Vol.14 (1), p.2063016-2063016

2022

Link zum Volltext

Verfügbarkeit prüfen

Tryptophan: 'essential' for the pathogenesis of irritable bowel syndrome?

Scandinavian journal of gastroenterology, 2014-12, Vol.49 (12), p.1493-1498

2014

Link zum Volltext

Verfügbarkeit prüfen

Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort

Gut microbes, 2020-05, Vol.11 (3), p.620-631

2020

Link zum Volltext

Verfügbarkeit prüfen

Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea

Scandinavian journal of gastroenterology, 2014-01, Vol.49 (1), p.43-51

2014

Link zum Volltext

Verfügbarkeit prüfen

Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome

Gut microbes, 2016-09, Vol.7 (5), p.397-413

2016

Link zum Volltext

Verfügbarkeit prüfen

Effect of fructose-reduced diet in patients with irritable bowel syndrome, and its correlation to a standard fructose breath test

Scandinavian journal of gastroenterology, 2013-08, Vol.48 (8), p.936-943

2013

Link zum Volltext

Verfügbarkeit prüfen

Mucosal cytokine imbalance in irritable bowel syndrome

Scandinavian journal of gastroenterology, 2008, Vol.43 (12), p.1467-1476

2008

Link zum Volltext

Verfügbarkeit prüfen

The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome

Expert review of gastroenterology & hepatology, 2017-02, Vol.11 (2), p.139-148

2017

Link zum Volltext

Verfügbarkeit prüfen

Plasticity of dorsal root ganglion neurons in a rat model of post-infectious gut dysfunction: potential implication of nerve growth factor

Scandinavian journal of gastroenterology, 2014-11, Vol.49 (11), p.1296-1303

2014

Link zum Volltext

Verfügbarkeit prüfen

Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism

Bioengineered, 2021-01, Vol.12 (1), p.1436-1444

2021

Link zum Volltext

Verfügbarkeit prüfen

Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome

Scandinavian journal of gastroenterology, 2017-12, Vol.52 (12), p.1331-1339

2017

Link zum Volltext

Verfügbarkeit prüfen

Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting

Scandinavian journal of gastroenterology, 2012-06, Vol.47 (6), p.619-624

2012

Link zum Volltext

Verfügbarkeit prüfen

Recent advances in the diagnosis of irritable bowel syndrome

Expert review of gastroenterology & hepatology, 2015-09, Vol.9 (9), p.1161-1174

El-Salhy, Magdy

2015

Link zum Volltext

Verfügbarkeit prüfen

Proteomics and irritable bowel syndrome

Expert review of proteomics, 2017-05, Vol.14 (5), p.461-468

2017

Link zum Volltext

Verfügbarkeit prüfen

The pregnane X receptor: from bench to bedside

Expert opinion on drug metabolism & toxicology, 2008-07, Vol.4 (7), p.895-908

2008

Link zum Volltext

Verfügbarkeit prüfen

Protective effect of eugenol against restraint stress-induced gastrointestinal dysfunction: Potential use in irritable bowel syndrome

Pharmaceutical biology, 2015-07, Vol.53 (7), p.968-974

2015

Link zum Volltext

Verfügbarkeit prüfen

New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline

Expert review of gastroenterology & hepatology, 2017-04, Vol.11 (4), p.285-292

2017

Link zum Volltext

Verfügbarkeit prüfen

Irritable bowel syndrome: focus on otilonium bromide

Expert review of gastroenterology & hepatology, 2014-02, Vol.8 (2), p.131-137

2014

Link zum Volltext

Verfügbarkeit prüfen

Fecal fat excretion in irritable bowel syndrome

Scandinavian journal of gastroenterology, 2012-09, Vol.47 (8-9), p.1120-1121

2012

Link zum Volltext

Verfügbarkeit prüfen

The role of human defensins in gastrointestinal diseases

Expert review of clinical immunology, 2011-11, Vol.7 (6), p.779-787

2011

Link zum Volltext

Verfügbarkeit prüfen

Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome

Expert opinion on investigational drugs, 2008-11, Vol.17 (11), p.1663-1670

2008

Link zum Volltext

Verfügbarkeit prüfen

Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis

Scandinavian journal of gastroenterology, 2006, Vol.41 (1), p.54-59

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 89

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Current Content Access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(89)

Sprache

Englisch
(89)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(86)
Science & Technology
(86)
Humans
(79)
Irritable Bowel Syndrome
(65)
Gastroenterology & Hepatology
(51)
Animals
(33)
Female
(31)
Male
(31)
Irritable Bowel Syndrome - Metabolism
(28)
Adult
(23)
Middle Aged
(19)
Irritable Bowel Syndrome - Drug Therapy
(18)
Pharmacology & Pharmacy
(18)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Microbiology
(16)
Irritable Bowel Syndrome - Diagnosis
(14)
Irritable Bowel Syndrome - Physiopathology
(14)
Gastroenterology. Liver. Pancreas. Abdomen
(13)
Other Diseases. Semiology
(13)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms

Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders

Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids

Integrated fecal microbiome-metabolome signatures reflect stress and serotonin metabolism in irritable bowel syndrome

Tryptophan: 'essential' for the pathogenesis of irritable bowel syndrome?

Changes in gut microbial metagenomic pathways associated with clinical outcomes after the elimination of malabsorbed sugars in an IBS cohort

Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea

Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome

Effect of fructose-reduced diet in patients with irritable bowel syndrome, and its correlation to a standard fructose breath test

Mucosal cytokine imbalance in irritable bowel syndrome

The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome

Plasticity of dorsal root ganglion neurons in a rat model of post-infectious gut dysfunction: potential implication of nerve growth factor

Effect of sodium butyrate regulating IRAK1 (interleukin-1 receptor-associated kinase 1) on visceral hypersensitivity in irritable bowel syndrome and its mechanism

Enteroendocrine, Musashi 1 and neurogenin 3 cells in the large intestine of Thai and Norwegian patients with irritable bowel syndrome

Subclinical mucosal inflammation in diarrhea-predominant irritable bowel syndrome (IBS) in a tropical setting

Recent advances in the diagnosis of irritable bowel syndrome

Proteomics and irritable bowel syndrome

The pregnane X receptor: from bench to bedside

Protective effect of eugenol against restraint stress-induced gastrointestinal dysfunction: Potential use in irritable bowel syndrome

New therapeutic options for IBS: the role of the first in class mixed µ- opioid receptor agonist and δ-opioid receptor antagonist (mudelta) eluxadoline

Irritable bowel syndrome: focus on otilonium bromide

Fecal fat excretion in irritable bowel syndrome

The role of human defensins in gastrointestinal diseases

Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome

Detection of inflammatory markers in stools from patients with irritable bowel syndrome and collagenous colitis

Aktive Filter

Suchergebnisse filtern